Schubert & Co - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schubert & Co ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$515
+10.0%
70.0%0.00%
Q4 2022$468
-53.2%
7
-12.5%
0.00%
-100.0%
Q3 2022$1,0000.0%8
+14.3%
0.00%0.0%
Q2 2022$1,0007
+250.0%
0.00%
Q1 2022$02
-33.3%
0.00%
Q4 2021$030.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders